Design and evaluation of novel tetracyclic benzofurans as palm site allosteric inhibitors of HCV NS5B polymerase. Issue 24 (15th December 2019)
- Record Type:
- Journal Article
- Title:
- Design and evaluation of novel tetracyclic benzofurans as palm site allosteric inhibitors of HCV NS5B polymerase. Issue 24 (15th December 2019)
- Main Title:
- Design and evaluation of novel tetracyclic benzofurans as palm site allosteric inhibitors of HCV NS5B polymerase
- Authors:
- Liu, Hong
Dai, Xing
He, Shuwen
Brockunier, Linda
Marcantonio, Karen
Ludmerer, Steven W.
Li, Fangbiao
Feng, Kung-I
Nargund, Ravi P.
Palani, Anandan - Abstract:
- Graphical abstract: Highlights: N-linked and C-linked tetracyclic benzofuran-based compounds were made and evaluated as HCV 5B non-nucleoside inhibitors. Tetracyclic benzofuran-based structures maintained broad spectrum anti-replicon potency profiles. Compounds demonstrated moderate to excellent oral bioavailability and pharmacokinetic parameters. C-linked tetracycle with 6-number ring displayed improved solubility and permeability compared to a clinical compound. Abstract: Hepatitis C virus (HCV) NS5B polymerase is a prime target for the development of direct-acting antiviral drugs for the treatment of chronic HCV infection. Several novel and potent HCV NS5B non-nucleoside inhibitors with unique tetracyclic bezonfuran-based structures were prepared and evaluated. Similar to clinical developmental compound MK-8876, N-linked (compounds 1 and 2 ) and C-linked (compounds 3 and 4 ) tetracyclic structures maintained broad spectrum anti-replicon potency profiles and demonstrated moderate to excellent oral bioavailability and pharmacokinetic parameters across the three preclinical animal species. To better understand the importance of tetracyclic structures related to pan genotypic potency profiles especially against clinically relevant GT1a variants, the teracycles with different ring size were prepared and in vitro evaluations suggested compounds with six number ring have better overall potency profiles.
- Is Part Of:
- Bioorganic & medicinal chemistry letters. Volume 29:Issue 24(2019)
- Journal:
- Bioorganic & medicinal chemistry letters
- Issue:
- Volume 29:Issue 24(2019)
- Issue Display:
- Volume 29, Issue 24 (2019)
- Year:
- 2019
- Volume:
- 29
- Issue:
- 24
- Issue Sort Value:
- 2019-0029-0024-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-12-15
- Subjects:
- Hepatitis C virus -- NS5B polymerase -- Non-nucleoside inhibitors (NNI) -- MK-8876 -- Tetracyclic structure
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
572 - Journal URLs:
- http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description ↗
http://www.sciencedirect.com/science/journal/0960894X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmcl.2018.10.045 ↗
- Languages:
- English
- ISSNs:
- 0960-894X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.330000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17951.xml